91 results about "Cardiac blood vessel" patented technology

A body implantable pressure sensor attached to an endocardial lead for implantation in a heart chamber or cardiac blood vessel for sensing blood pressure and providing blood pressure signals to an implanted or external hemodynamic monitor and / or therapy delivery device and method of fabrication thereof. A pressure sensor module is formed of an elongated receptacle having an elongated receptacle cavity for receiving a calibrated, micro-machined pressure transducer having a pressure responsive element. The receptacle cavity is covered by a diaphragm disposed alongside the lead body and in parallel with the lead axis. The receptacle cavity is filled with a incompressible oil for transferring pressure forces that are applied to the diaphragm to the pressure transducer. The oil is introduced through a fill port, and the fill port is sealed after the oil is introduced to prevent leakage of the oil from the receptacle cavity and to complete the hermetic sealing of the receptacle cavity. The fill port further comprises a fill tube having a fill tube lumen extending outward of an end wall of the receptacle cavity to a fill tube end, and said sealing step further comprises the steps of crimping or otherwise obstructing the fill tube end to close the fill tube lumen, fitting a fill port cover having an abutting edge over the crimped fill tube end and against the end wall of the receptacle to enclose the sealed fill tube end within a fill port cover cavity, and sealing the abutting edge against the receptacle end wall to hermetically enclose the sealed fill tube end within the fill port cover cavity.

Methods and apparatus employed in surgery involving making precise incisions in vessels of the body, particularly cardiac blood vessels in coronary revascularization procedures conducted on the stopped or beating heart are disclosed. Such incisions are created by applying an elongated electrosurgical cutting electrode to the outer surface of the vessel wall in substantially parallel alignment with the body vessel axis, the elongated electrosurgical cutting electrode having a predetermined cutting electrode length exceeding the cutting electrode width. RF energy is applied between the electrosurgical cutting electrode and the ground electrode at an energy level and for a duration sufficient to cut an elongated slit through the vessel wall where the elongated electrosurgical cutting electrode is applied to the surface of the vessel wall.

The present invention refers to the field of cardiac electrophysiology (EP) and, more specifically, to image-guided radio frequency ablation and pacemaker placement procedures. For those procedures, it is proposed to display the overlaid 2D navigation motions of an interventional tool intraoperatively obtained from the same projection angle for tracking navigation motions of an interventional tool during an image-guided intervention procedure while being navigated through a patient's bifurcated coronary vessel or cardiac chambers anatomy in order to guide e.g. a cardiovascular catheter to a target structure or lesion in a cardiac vessel segment of the patient's coronary venous tree or to a region of interest within the myocard. In such a way, a dynamically enriched 2D reconstruction of the patient's anatomy is obtained while moving the interventional instrument. By applying a cardiac and / or respiratory gating technique, it can be provided that the 2D live images are acquired during the same phases of the patient's cardiac and / or respiratory cycles. Compared to prior-art solutions which are based on a registration and fusion of image data independently acquired by two distinct imaging modalities, the accuracy of the two-dimensionally reconstructed anatomy is significantly enhanced.

One embodiment discloses a computerized method of assessing deposits and / or blockages in blood vessels in a human, specifically in a human heart. The method may include inputting patient data and creating a computerized interactive model of a heart based on the patient data. Patient data may include a plurality of images of a least a portion of a human heart. Images may include three-dimensional images. An image may be divided into regions. A property of a region may be assessed. A property may include intensity of brightness of a region or a portion of a region. A region may include one or more voxels or one or more pixels. A method may include comparing a property of a region of a heart from a first image to a second image. The first image and the second image may include equivalent regions acquired during different time periods.

A device for non-invasively measuring at least one parameter of a cardiac blood vessel in a patient is provided. The device comprises at least one light source that emits light in the 400 nm to 1000 nm wavelength range; at least one photodetector adapted to receive light emitted by the light source and generate an output based on the received light, wherein said light is reflected from or transmitted through tissue of the patient, the output of said photodetector being correlated with a parameter of the blood vessel; and at least one probe for facilitating delivery of light from the light source to an external tissue site on the patient in the proximity of the cardiac blood vessel and receipt of light by the photodetector. A system and methods of monitoring / measuring cardiac parameters utilizing the device and / or system are also provided.

An ablation device for cardiac tissue, especially for forming a circular lesion around a vessel orifice in the heart, comprises a steerable catheter that is provided in the region of its distal end with an abutment device for holding the distal end of the catheter on a cardiac vessel orifice; and a linear ablation applicator that is disposed distally or proximally relative to the abutment device of the catheter and can be brought from a straight passive position into a radially expanded, approximately circular-arc-type encircling ablation position.

Guide catheters and methods of using same for facilitating implantation of cardiac leads for applying electrical stimulation to and / or sensing electrical activity of the heart through one or more electrode positioned at an implantation site within a heart chamber or cardiac vessel adjacent a heart chamber and more particularly to a method and apparatus for introducing such a cardiac lead having low torqueability and pushability through a pathway to enable attachment of the cardiac lead at the implantation site are disclosed. The catheter body comprises delivery lumen to introduce a small diameter cardiac lead and a guide lumen to receive a guide tool to locate the catheter body distal end at the implantation site. The small diameter lumen within a small diameter guide tube extends distally from the delivery exit port of the delivery lumen. The catheter body is shaped to bias the delivery lumen exit port toward the heart.

An angiographic injector system and a method of controllably delivering medical fluid to a patient from an angiographic injector system are disclosed. A multiple processor control system is used to actively control the injection process and to monitor sensed functions of the system. The multiple processors provide dual redundancy safety circuits for critical control functions such as syringe motor drive speed and current. A motor / servo-amplifier nested control function is also disclosed. A unique method and apparatus are disclosed for establishing injection parameter default values just prior to an injection procedure that are based on physiological values of the patient to be treated. The injector system uses an interactive display panel that presents sequenced set-up screens to the user and which enables the user to select injection procedures, parameters and other modes of operation directly through the interactive panel.

The present invention provides an improved method for reducing the risk or severity of restenosis following cardiac angioplasty. The method includes administering to a target vessel region, a morpholino antisense compound having a phosphorus-containing backbone linkages, and spanning the start codon of a human c-myc mRNA. Also disclosed are novel antisense compounds and compositions, and a method for assaying the effectiveness of antisense delivery and uptake to a target vessel region.

Cardioplegia is delivered to a heart vessel by conducting the cardioplegia through an infusion lumen of a cannula. The cardioplegia communicates with a balloon disposed on a distal end of the cannula to cause the cardioplegia to inflate the balloon into sealing contact with a wall of the coronary sinus. The flow of cardioplegia is halted while preventing drainage of cardioplegia from the balloon, to maintain the balloon in its inflated state until such time as the flow of cardioplegia is resumed. Drainage of cardioplegia from the balloon is prevented by causing a valve to be shifted to a closed position blocking communication between the infusion lumen and the balloon. The valve can be shifted manually, or automatically in response to the halting of the delivery of cardioplegia.

MR spectroscopy and imaging method for imaging pulmonary and cardiac vasculature and the cardiac region and evaluating blood flow or circulatory deficits use dissolved phase polarized 129Xe gas and large flip angle excitation pulses. Pulmonary and cardiac vasculature MRI images are obtained by delivering gas to a patient via inhalation such as with a breath-hold delivery-procedure, exciting the dissolved phase gas with a large flip angle pulse, and generating a corresponding image. Preferably, the image is obtained using multi-echo imaging techniques. Blood flow is quantified using low field MR spectroscopy and an RF excitation pulse with a frequency which corresponds to the resonance of the dissolved phase 129Xe.

An angiographic injector system and a method of controllably delivering medical fluid to a patient from an angiographic injector system are disclosed. A multiple processor control system is used to actively control the injection process and to monitor sensed functions of the system. The multiple processors provide dual redundancy safety circuits for critical control functions such as syringe motor drive speed and current. A motor / servo-amplifier nested control function is also disclosed. A unique method and apparatus are disclosed for establishing injection parameter default values just prior to an injection procedure that are based on physiological values of the patient to be treated. The injector system uses an interactive display panel that presents sequenced set-up screens to the user and which enables the user to select injection procedures, parameters and other modes of operation directly through the interactive panel.

The present invention relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in 18F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs. In some embodiments, methods and compositions for assessing perfusion and innervation mismatch in a portion of a subject are provided.

The movement of catheters and guide wires for catheters with the aid of magnets is known from the field of cardiology. Conventional magnets are, as a result of their size, not suited to being inserted into the brain of patient, because the vessels there are smaller than the cardiac vessels. To enable the navigation methods proven in cardiology also to be used in neurology, the invention provides a microcatheter having a guide wire, which features magnetic nanoparticles. The magnetic nanoparticles can be provided in the form of a ferrofluid or also as diamond nanoparticles in powder form. This enables navigation of the guide wire and thus ultimately of the catheter in the brain from the outside by way of magnetic fields.

The present invention provides an improved method for reducing the risk or severity of restenosis following cardiac angioplasty. The method includes administering to a target vessel region, a morpholino antisense compound having uncharged phosphorus-containing backbone linkages, and spanning the start codon of a human c-myc mRNA. Also disclosed are novel antisense compounds and compositions, and a method for assaying the effectiveness of antisense delivery and uptake to a target vessel region.

The present invention provides compounds with imaging moieties for imaging a subject. The present invention also relates to systems, compositions, and methods for the synthesis and use of imaging agents, or precursors thereof. An imaging agent precursor may be converted to an imaging agent using the methods described herein. In some cases, a composition or plurality of imaging agents is enriched in 18 F. In some cases, an imaging agent may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

A device for non-invasively measuring parameters of a cardiac blood vessel in a patient is provided. The device comprises at least one light source that emits light in the 400 nm to 1000 nm wavelength range and at least one photodetector adapted to receive light emitted by the light source, which light is reflected from or transmitted through tissue of the patient, the output of said photodetector correlating with a parameter of the blood vessel. The device also includes a probe which permits delivery of light from the light source to an external tissue site on the patient in the proximity of a cardiac blood vessel and permits the photodetector to receive light originating from the light source which has been reflected from or transmitted through tissue at the patient site.

The present invention relates to a method for automatic road mapping for heart valve replacement and an examination apparatus for automatic road mapping for heart valve replacement. In order to provide the cardiologist or surgeon with better information during PHV implantation, an examination apparatus for automatic roadmapping for heart valve replacement is provided, that comprises at least one X-ray image acquisition device (10), a calculation unit (18) and a display device (20). The image acquisition device is adapted to acquire (32) at least one X-ray image of a vessel root region of a heart with injected contrast agent and to acquire (46) at least one current fluoroscopy image of the vessel root region with a replacement valve inserted into the vessel. The calculation unit is adapted to identify (34) vessel information data within the at least one acquired image, to model (36) vessel root representation using the vessel information data and to generate (44) a composite image by a combination of the model of the vessel root representation with the at least one fluoroscopy image. The display unit is adapted to display (48) the composite image.

The present invention generally relates to novel synthetic methods, systems, kits, salts, and precursors useful in medical imaging. In some embodiments, the present invention provides compositions comprising an imaging agent precursor, which may be formed using the synthetic methods described herein. An imaging agent may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in 18F. In some cases, an imaging agent including salt forms (e.g., ascorbate salt) may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

A method and apparatus for using a secondary refrigerant to precool and liquefy a primary refrigerant, then vaporizing and expanding the primary refrigerant to cool a cold tip of a cryosurgical instrument for ablation of biological tissue, such as cardiovascular tissue, in particular endocardiac tissue and tissue inside a cardiac blood vessel. The secondary refrigerant has a critical temperature above the critical temperature of the primary refrigerant, and a cooling temperature below the critical temperature of the primary refrigerant, thereby facilitating the use of the precooling step to provide liquid primary refrigerant in an operating room environment in which the primary refrigerant could not otherwise be provided in the liquid phase.

The invention discloses a method for calculating heart and vessel functional parameters based on blood pressure and pulses of four limbs, and belongs to the technical field of biomechanics. The arterial blood pressure and pressure pulse waves of the four limbs are detected through a pulse wave sensor and a blood pressure sensor, and noninvasive synchronous detection on the heart function, the rete arteriosum hardenability and blood flow parameters of the heart and the vascular function is achieved. The method comprises the steps that blood pressure and pulse wave information of the brachial artery and ankle artery of the four limbs are firstly collected, a series of collected pulse waves are subjected to waveform averaging, and average waveforms of the brachial artery and ankle artery of the four limbs are obtained respectively. The relation between the pulse waves of the four limbs, a pressure gradient and blood flow is set up based on the waveform characteristic parameters acquired through waveform analysis and the nonlinear pulse wave theory, and then the heart and vessel functional parameters are calculated on the basis of the blood flow and four limb pulse and blood pressure data. According to the method, a frequent and noninvasive detecting means easy to operate, fast in output and low in price is provided for a heart and vessel system.

Various methods and devices for treating a patient who has lost, or is at risk of losing cardiac function by cardiac ischemia are disclosed. Treatment includes first imaging a patient's heart, or a portion thereof, to identify underperfused regions of cardiac muscle, and a source of oxygenated blood that is proximate to the underperfused region. Between the underperfused regions and the oxygenated blood source, a target area is selected where thermal or mechanical injury is introduced, and optionally reintroduced, to convert initial capillary blush, resulting from the injury.

Methods and systems for treating patients suffering from or at risk of cardiac arrhythmias rely on the injection of amiodarone and other class III anti-arrhythmic drugs into the perivascular space surrounding a cardiac blood vessel. Injection may be achieved using intravascular catheters which advance needles radially outward from a blood vessel lumen or by transmyocardial injection from an epicardial surface of the heart.

Cardioplegia is delivered to a heart vessel by conducting the cardioplegia through an infusion lumen of a cannula. The cardioplegia communicates with a balloon disposed on a distal end of the cannula to cause the cardioplegia to inflate the balloon into sealing contact with a wall of the coronary sinus. The flow of cardioplegia is halted while preventing drainage of cardioplegia from the balloon, to maintain the balloon in its inflated state until such time as the flow of cardioplegia is resumed. Drainage of cardioplegia from the balloon is prevented by causing a valve to be shifted to a closed position blocking communication between the infusion lumen and the balloon. The valve can be shifted manually, or automatically in response to the halting of the delivery of cardioplegia.

The present invention generally relates to novel synthetic methods, systems, kits, salts, and precursors useful in medical imaging. In some embodiments, the present invention provides compositions comprising an imaging agent precursor, which may be formed using the synthetic methods described herein. An imaging agent may be converted to an imaging agent using the methods described herein. In some cases, the imaging agent is enriched in 18F. In some cases, an imaging agent including salt forms (e.g., ascorbate salt) may be used to image an area of interest in a subject, including, but not limited to, the heart, cardiovascular system, cardiac vessels, brain, and other organs.

The invention discloses a vascular stenosis analysis method, and the method comprises the steps: determining a target image region comprising a blood vessel and a plaque from a target heart CT angiography image, carrying out the segmentation of the target image region, obtaining a segmented blood vessel image and a plaque image, and based on the segmented blood vessel image and plaque image, determining a target vascular stenosis analysis result corresponding to the target heart CT angiography image so that the patch size is very small compared with a blood vessel and a background, and compared with the target heart CT angiography image, a large amount of redundant information is removed from the target image area, thus the preset segmentation model can avoid the interference of a large amount of redundant information in the target heart CT angiography image, and accurately segment plaques and blood vessels in the target image region, i.e., the segmentation accuracy of the plaques andthe blood vessels is improved; therefore, the accuracy of the target vascular stenosis analysis result corresponding to the target heart CT angiography image can be improved.

The present invention provides a Kawasaki disease and fever diagnosis system based on embedding of an incremental local discrimination subspace. The Kawasaki disease and fever diagnosis system comprises a training subsystem and a diagnostic subsystem. The training subsystem has the tasks of generating clinical manifestations for use of training from historical medical records of children with Kawasaki disease and a common fever, detecting physiological data, then analyzing local structure information, and searching for an optimal local discrimination subspace to establish a Kawasaki disease and fever feature model therein. Furthermore, when a new patient medical record is acquired, the training subsystem updates the model in an incremental learning manner. The diagnostic subsystem has the tasks of observing clinical manifestations of patients to be diagnosed, detecting physiological data, and determining whether the patients suffer from Kawasaki disease according to the Kawasaki disease and fever feature model established by the training subsystem. The present invention enables children suffering from Kawasaki disease to be treated in time, reducing the probability of developing into coronary artery dilatation or aneurysm, and alleviating the cardiovascular damage of the patients.